Your browser doesn't support javascript.
loading
Transcriptomic and Immunohistochemical Profiling of SLC6A14 in Pancreatic Ductal Adenocarcinoma.
Penheiter, Alan R; Erdogan, Sibel; Murphy, Stephen J; Hart, Steven N; Felipe Lima, Joema; Rakhshan Rohakhtar, Fariborz; O'Brien, Daniel R; Bamlet, William R; Wuertz, Ryan E; Smyrk, Thomas C; Couch, Fergus J; Vasmatzis, George; Bender, Claire E; Carlson, Stephanie K.
Afiliação
  • Penheiter AR; Department of Molecular Medicine, Mayo Clinic, 200 First Street SW, Rochester, MN 55905, USA.
  • Erdogan S; Department of Biochemistry and Molecular Biology, Mayo Clinic, 200 First Street SW, Rochester, MN 55905, USA.
  • Murphy SJ; Department of Molecular Medicine, Mayo Clinic, 200 First Street SW, Rochester, MN 55905, USA.
  • Hart SN; Biomedical Statistics and Informatics, Mayo Clinic, 200 First Street SW, Rochester, MN 55905, USA.
  • Felipe Lima J; Department of Molecular Medicine, Mayo Clinic, 200 First Street SW, Rochester, MN 55905, USA.
  • Rakhshan Rohakhtar F; Medical Genome Facility, Mayo Clinic, 200 First Street SW, Rochester, MN 55905, USA.
  • O'Brien DR; Biomedical Statistics and Informatics, Mayo Clinic, 200 First Street SW, Rochester, MN 55905, USA.
  • Bamlet WR; Biomedical Statistics and Informatics, Mayo Clinic, 200 First Street SW, Rochester, MN 55905, USA.
  • Wuertz RE; Department of Epidemiology, Mayo Clinic, 200 First Street SW, Rochester, MN 55905, USA.
  • Smyrk TC; Department of Anatomic Pathology, Mayo Clinic, 200 First Street SW, Rochester, MN 55905, USA.
  • Couch FJ; Department of Laboratory Medicine and Pathology, Mayo Clinic, 200 First Street SW, Rochester, MN 55905, USA.
  • Vasmatzis G; Department of Molecular Medicine, Mayo Clinic, 200 First Street SW, Rochester, MN 55905, USA.
  • Bender CE; Department of Radiology, Mayo Clinic, 200 First Street SW, Rochester, MN 55905, USA.
  • Carlson SK; Department of Molecular Medicine, Mayo Clinic, 200 First Street SW, Rochester, MN 55905, USA ; Department of Radiology, Mayo Clinic, 200 First Street SW, Rochester, MN 55905, USA.
Biomed Res Int ; 2015: 593572, 2015.
Article em En | MEDLINE | ID: mdl-26106611
ABSTRACT
We used a target-centric strategy to identify transporter proteins upregulated in pancreatic ductal adenocarcinoma (PDAC) as potential targets for a functional imaging probe to complement existing anatomical imaging approaches. We performed transcriptomic profiling (microarray and RNASeq) on histologically confirmed primary PDAC tumors and normal pancreas tissue from 33 patients, including five patients whose tumors were not visible on computed tomography. Target expression was confirmed with immunohistochemistry on tissue microarrays from 94 PDAC patients. The best imaging target identified was SLC6A14 (a neutral and basic amino acid transporter). SLC6A14 was overexpressed at the transcriptional level in all patients and expressed at the protein level in 95% of PDAC tumors. Very little is known about the role of SLC6A14 in PDAC and our results demonstrate that this target merits further investigation as a candidate transporter for functional imaging of PDAC.
Assuntos

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Adenocarcinoma / Biomarcadores Tumorais / Carcinoma Ductal Pancreático / Sistemas de Transporte de Aminoácidos Neutros Limite: Aged / Female / Humans / Male / Middle aged Idioma: En Revista: Biomed Res Int Ano de publicação: 2015 Tipo de documento: Article País de afiliação: Estados Unidos

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Adenocarcinoma / Biomarcadores Tumorais / Carcinoma Ductal Pancreático / Sistemas de Transporte de Aminoácidos Neutros Limite: Aged / Female / Humans / Male / Middle aged Idioma: En Revista: Biomed Res Int Ano de publicação: 2015 Tipo de documento: Article País de afiliação: Estados Unidos